Last reviewed · How we verify
Ketamine infusion
Ketamine infusion is a Small molecule drug developed by Yale University. It is currently FDA-approved. Also known as: Ketalar, Ketamine hydrochloride, hyperalgesia-blocker.
At a glance
| Generic name | Ketamine infusion |
|---|---|
| Also known as | Ketalar, Ketamine hydrochloride, hyperalgesia-blocker |
| Sponsor | Yale University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Electroencephalographic (EEG) Profils for Patients on Intravenous Ketamine.
- Management of Pain in Lumbar Arthrodesis (PHASE4)
- Neurobiology of Suicide (PHASE2)
- Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery (PHASE1)
- Ketamine + Cognitive Training for Suicidality in the Medical Setting (PHASE4)
- Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal Thoughts (PHASE4)
- Erector Spinae Block Vs Ketamine-based Multimodal Analgesia Protocol in Lumber Decompressive Surgery (NA)
- Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ketamine infusion CI brief — competitive landscape report
- Ketamine infusion updates RSS · CI watch RSS
- Yale University portfolio CI
Frequently asked questions about Ketamine infusion
What is Ketamine infusion?
Ketamine infusion is a Small molecule drug developed by Yale University.
Who makes Ketamine infusion?
Ketamine infusion is developed and marketed by Yale University (see full Yale University pipeline at /company/yale-university).
Is Ketamine infusion also known as anything else?
Ketamine infusion is also known as Ketalar, Ketamine hydrochloride, hyperalgesia-blocker.
What development phase is Ketamine infusion in?
Ketamine infusion is FDA-approved (marketed).
Related
- Manufacturer: Yale University — full pipeline
- Also known as: Ketalar, Ketamine hydrochloride, hyperalgesia-blocker
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing